[LIPO] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[LIPO] Lipella Pharmaceuticals Inc.
Announcement Date
13-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- -78,603.52%
YoY- -60,858.15%
Quarter Report
LIPO's Result
LIPO's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 CAGR
Revenue 136,431 106,676 0 149 869.03%
PBT -938 -1,539 -782 -342 39.93%
Tax 0 36,477 -1 -340 -
NP -938,146 -1,539 -781 -342 1296.48%
Tax Rate - - - - -
Total Cost 1,074,577 108,215 781 491 1195.29%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 CAGR
NP Margin -687.63 -1.44 0.00 -229.28 44.16%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 CAGR
EPS -0.12 -0.27 -0.14 -0.06 25.96%
EPS Diluted -0.12 -0.27 -0.14 -0.06 25.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.